Skip to main content

Table 3 PPH diagnosis and blood loss

From: A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage

 

Miso + Placebo

N = 128

Miso + TXA

N = 130

Median Blood loss at PPH diagnosis

700 (500–1200)

700 (500–1500)

Reason for PPH

 Uterine atony (among causes)

118 (92.2)

119 (91.5)

 Uterine atony alone

91 (71.1)

89 (69.5)

 Uterine atony + other causea

27 (21.3)

30 (23.4)

 Non atonic cause

9 (7.1)

9 (7.0)

Median blood loss at treatment

700 (500–2000)

700 (500–1500)

Median blood loss at 20 min post treatment

750 (500–2200)

750 (550–1600)

Median blood loss at 40 min post treatment

800 (500–2300)

800 (550–2000)

Median blood loss at 1 h post treatment

800 (500–2300)

800 (550–2000)

Median blood loss at 2 h post treatment

800 (500–2300)

800 (550–2000)

Time to bleeding controlled post treatment

 Mean

33 min (0-2 h)

33 min (0-2 h)

 Median

20 min

20 min

Mean time to bleeding controlled post

23 min (N = 74)

28 min (N = 74)

treatment- TXT DRUG ONLY

Median: 20 min

Median: 20 min

Mean time to bleeding controlled post

48 min (N = 52)

41 (N = 54)

treatment- ADDITIONAL INTERVENTIONS

Median: 30 min

Median:30 min

  1. There were no statistically significant differences between the two groups for any of these variables
  2. aOther causes included cervical or perineal lacerations and retained placenta